Published May 2021 | Version v1
Journal article

Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat

  • 1. Department of Pharmacology, Israel Institute for Biological, Chemical and Environmental Sciences, Ness-Ziona 74100 (Israel)

Description

Highlights: • Exposure to the nerve agent sarin induces status epilepticus refractive seizures. • Late benzodiazepine treatment is insufficient in mitigating refractive seizures. • Combination of midazolam, ketamine and valproate attenuates refractive seizures. • A 1 h delayed combined treatment alleviates the epileptiform seizure activity. • The combined treatment prevents biochemical and histopathological neurotoxicity. The development of refractory status epilepticus (SE) induced by sarin intoxication presents a therapeutic challenge. In our current research we evaluate the efficacy of a delayed combined triple treatment in ending the abnormal epileptiform seizure activity (ESA) and the ensuing of long-term neuronal insult. SE was induced in male Sprague-Dawley rats by exposure to 1.2LD50 sarin insufficiently treated by atropine and TMB4 (TA) 1 min later. Triple treatment of ketamine, midazolam and valproic acid was administered 30 min or 1 h post exposure and was compared to a delayed single treatment with midazolam alone. Toxicity and electrocorticogram activity were monitored during the first week and behavioral evaluation performed 3 weeks post exposure followed by brain biochemical and immunohistopathological analyses. The addition of both single and triple treatments reduced mortality and enhanced weight recovery compared to the TA-only treated group. The triple treatment also significantly minimized the duration of the ESA, reduced the sarin-induced increase in the neuroinflammatory marker PGE2, the brain damage marker TSPO, decreased the gliosis, astrocytosis and neuronal damage compared to the TA+ midazolam or only TA treated groups. Finally, the triple treatment eliminated the sarin exposed increased open field activity, as well as impairing recognition memory as seen in the other experimental groups. The delayed triple treatment may serve as an efficient therapy, which prevents brain insult propagation following sarin-induced refractory SE, even if treatment is postponed for up to 1 h.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.taap.2021.115519

Additional details

Identifiers

DOI
10.1016/j.taap.2021.115519;
PII
S0041008X21001265;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
419
Journal Page Range
vp.
ISSN
0041-008X
CODEN
TXAPA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54051926
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ATROPINE; BRAIN; MORTALITY; NERVES; RATS; THERAPY; TOXICITY
Descriptors DEC
ALKALOIDS; ANIMALS; AUTONOMIC NERVOUS SYSTEM AGENTS; BODY; CENTRAL NERVOUS SYSTEM; DRUGS; MAMMALS; MEDICINE; NERVOUS SYSTEM; ORGANIC COMPOUNDS; ORGANS; PARASYMPATHOLYTICS; RODENTS; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.